Ocular Therapeutix Inc (OCUL)
9.84
+0.61
(+6.61%)
USD |
NASDAQ |
Oct 04, 16:00
9.84
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Shareholders Equity (Annual): 91.13M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 91.13M |
| December 31, 2022 | 35.38M |
| December 31, 2021 | 88.00M |
| December 31, 2020 | 76.10M |
| December 31, 2019 | -3.63M |
| December 31, 2018 | 35.88M |
| Date | Value |
|---|---|
| December 31, 2017 | 26.15M |
| December 31, 2016 | 52.01M |
| December 31, 2015 | 89.59M |
| December 31, 2014 | 58.70M |
| December 31, 2013 | -59.47M |
| December 31, 2012 | -46.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-3.63M
Minimum
2019
91.13M
Maximum
2023
57.39M
Average
76.10M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Marinus Pharmaceuticals Inc | 16.76M |
| Aptevo Therapeutics Inc | 12.22M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |